Get a glimpse into our company and investor data—powered by the PitchBook Platform
A portfolio of rights for regenerative therapies. The assets include distribution rights for genetically engineered xenogeneic tissues.
This information is reserved for PitchBook Platform users. To explore Revivicor (rights for regenerative therapies)‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.